Adiponectin in chronic kidney disease: A complex and context sensitive clinical situation

Journal of Renal Nutrition

Volumn 21, Issue 1, 2011, Pages 82-86

  Stenvinkel, Peter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; HUMAN; METABOLIC DISORDER; REVIEW; RISK FACTOR; WASTING SYNDROME;

ADIPONECTIN; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; METABOLIC DISEASES; RISK FACTORS; WASTING SYNDROME;

EID: 78650707102     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.10.019     Document Type: Review

References (16)

1. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
2. Park S.H., Carrero J.J., Lindholm B., et al. Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin. Clin Nephrol 2009, 72:87-96.
3. Kistorp C., Faber J., Galatius S., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112:1756-1762.
4. Matsumoto M., Ishikawa S., Kajii E. Adiponectin and noncardiovascular death: a nested case-control study. Metabolism 2008, 57:811-818.
5. Marchlewska A., Stenvinkel P., Lindholm B., et al. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int 2004, 66:46-50.
6. Barazzoni R., Bernardi A., Biasia F., et al. Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease-impact on plasma adiponectin concentration. Am J Physiol Regul Integr Comp Physiol 2007, 293:R47-R54.
7. Shen Y.Y., Charlesworth J.A., Kelly J.J., et al. Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant 2007, 22:171-178.
8. Qi Y., Takahashi N., Hileman S.M., et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004, 10:524-529.
9. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
10. Fruebis J., Tsao T.S., Javorschi S., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001, 98:2005-2010.
11. Ohashi N., Kato A., Misaki T., et al. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients. Intern Med 2008, 47:485-491.
12. Ix J.H., Sharma K. Mechanisms linking obesity, chronic kidney disease and fatty liver disease: the roles of fetuin-A, adiponectin and AMPK. J Am Soc Nephrol 2010, 21:406-412.
13. Sharma K., Ramachandrarao S., Qiu G., et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008, 118:1645-1656.
14. Targher G., Bertolini L., Chonchol M., et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 2010, 53:1341-1348.
15. Tsukamoto O., Fujita M., Kato M., et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 2009, 53:2070-2077.
16. Kamari Y., Shimoni N., Koren F., et al. High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system. J Hypertens 2010, 28:95-101.